My lab studies the underlying pharmacology of psychiatric disorders, such as drug abuse, anxiety and depression as well as pain disorders.
Area of Research:
- Biophysical and Computational Chemistry
- Genomics and Systems Biology
- Medicinal Chemistry and Chemical Biology
- Molecular and Cellular Pharmacology
Disease Area:
- Neuroscience
- Cancer
- Metabolism
- Aging
- Infectious Disease
- Immunology
- Drug Addiction
- Alzheimer's Disease
- Rare Diseases
Current projects involve investigations into the risk of the alcohol mixed energy drinks, the role of beta-arrestin dependent signaling in depression and anxiety disorders, the physiological function of opioid-dopamine interactions and alcohol withdrawal induced hyperalgesia.
Keywords: Alcohol use disorders, delta opioid receptor, drug development, psychiatric disorders, psychostimulant use, behavioral neuropharmacology, g protein-coupled receptors
Research: G-protein coupled receptor pharmacology of addiction and neurological disorders
Subject Areas:
- drug addiction
- neuroscience
Area of research:
- Molecular and Cellular Pharmacology
I have an extensive training in drug discovery at G protein-coupled opioid receptors (GPCR) pharmacology. My independent research has primarily focused on investigating the delta opioid receptor (δOR) as a novel target for the treatment of (co-morbid) pain, alcohol use and mood disorders.
